GLAXOSMITHKLINE NEBRASKA

FDA Regulatory Profile

GLAXOSMITHKLINE NEBRASKA appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0088-2019, Class II) was initiated on September 26, 2018.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0088-2019Class IIPrevacid 24HR (Lansoprazole) delayed-release capsules, 15 mg, 14 capsules per bottle in a carton conSeptember 26, 2018